K.E.M. Hospital Mumbai Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2004
NCT00610324
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Department of Pediatrics, KEM Hospital Research Centre, Pune, India | K.E.M. Hospital Mumbai,Maharashtra,India | Professor of Medicine, K E M Hospital, Parel, Mumbai 400012, India

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Healthcare-Associated Pneumonia (Phase 4)

Pneumonia (Phase 4)

Pneumonia, Aspiration (Phase 4)

Pneumonia, Ventilator-Associated (Phase 4)

Poisoning (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5